Navigation Links
Computational Biology Market - New Market Research Report Published by Transparency Market Research
Date:5/14/2013

Albany, New York (PRWEB) May 14, 2013

Computational biology uses sequencing, databases and supercomputers for analysis and algorithm formation to predict the molecules that can be taken for drug identification and lead optimization. Setbacks in drug discovery with absence of potential blockbusters in the market coupled with cost containment issues faced by major drug manufacturers has compelled the major players to shift their focus to newer methods of drug discovery in order to help accelerate the drug development process and bring down R&D expenditure.

Related Report : Medical Robotic Systems Market
http://www.transparencymarketresearch.com/medical-robotic-systems.html

The drug discovery market is the fastest growing segment and is anticipated to grow at a CAGR of more than 25% from 2012 to 2018. The use of computational biology for drug discovery now offers manufacturers a method to reduce R&D expenditure and to reduce chances of late stage failure of drug candidates. Computational software and simulation tools are being used in various stages of drug discovery to minimize the future risks of drug failure in later stages of drug development.

Browse the full report with TOC at http://www.transparencymarketresearch.com/computational-biology.html

Geographically, North America constituted the largest market in the year 2011. This has been partly due to an encouraging environment for this field created by the US FDA and intense R&D efforts in this region by major pharmaceutical players. The U.S. Federal Government has been supportive through provision of funds for R&D; additionally, academic centres use modelling and simulation for drug discovery. However, Asia is expected to be the fastest growing region due to the emergence of many small regional players as well as lower operating costs as compared to the developed markets.

Related Report : Fundus Cameras Market
http://www.transparencymarketresearch.com/fundus-cameras.html

The global computational biology market is predominantly ruled by major players namely Schrödinger, Accelrys, Certara, Compugen, Simulation Plus, Entelos and others. The market is oligopolistic and these major players account for almost 80% of the market share.

Browse all market research reports: http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/5/prweb10731089.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Computational analysis identifies drugs to treat drug-resistant breast cancer
2. PhUSE Co-sponsors the Annual FDA/PhUSE Computational Science Symposium, in Silver Spring Maryland, USA, March 18th-19th 2013
3. National initiative launched to change the way biology departments approach undergraduate education
4. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
5. Notre Dame researchers paper examines the biology of tumor-derived microvesicles
6. Biology Leaves Gay Men Highly Vulnerable to HIV: Study
7. Boston University researchers expand synthetic biologys toolkit
8. Microbiology and Genome Experts Quell Deadly Bacteria Outbreak
9. College biology faculty named Leadership Fellows
10. American Physiological Society’s October conference examines the integrative biology of exercise
11. CSHL Press releases new book on the biology of drug addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , ... July 21, 2017 , ... ... received a $5,000 grant from the C. R. Bard Foundation, Inc. ... at Somerset Hills , a service available through the nonprofit home care agency. ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) ... progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a ... relapse. With such a challenging diagnosis that requires immediate action, patients and ...
(Date:7/20/2017)... ... 20, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is teaming up with a Microsoft Corp. employee-led hackathon team for the 2017 ... , “Team Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: